Key facts
- Notable investors include Ben Franklin Technology Partners of Central and Northern Pennsylvania.
- Status: Privately Held (backing).
- ·The complete investor list — 1 names
- ·Watchlist + deal alerts for ABEC
- ·The full record, as it builds
Funding rounds
No funding rounds for ABEC are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About ABEC
Provider of customized bioprocess services designed to enable efficient manufacturing of biopharmaceutical products. The company offers integrated single-use, stainless steel equipment manufacturing, automation integration, and hybrid systems for vaccine, antibody, and gene therapy production, allowing biopharmaceutical manufacturers to enhance productivity, reduce costs, and accelerate time to market.
- Sector
- Business Products and Services (B2B)
- HQ
- Bethlehem, PA, United States
- Founded
- 1974
- Employees
- 553
- Website
- abec.com/
- Ownership
- Privately Held (backing)
ABEC doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in ABEC shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on ABEC in its N-PORT filings yet. We sweep new filings monthly.